An early-phase study of azacitidine and lenalidomide for untreated elderly acute myeloid leukemia (AML) patients

被引:0
|
作者
Pollyea, D. A.
Kohrt, H. E.
Rajwanshi, R.
Gallegos, L.
Berube, C.
Coutre, S. E.
Gotlib, J. R.
Liedtke, M.
Mitchell, B. S.
Medeiros, B. C.
机构
[1] Stanford Canc Ctr, Stanford, CA USA
[2] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.tps280
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS280
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry
    Pleyer, Lisa
    Burgstaller, Sonja
    Stauder, Reinhard
    Girschikofsky, Michael
    Linkesch, Werner
    Pfeilstoecker, Michael
    Autzinger, Eva Maria
    Tinchon, Christoph
    Sliwa, Thamer
    Lang, Alois
    Sperr, Wolfgang R.
    Geissler, Dietmar
    Krippl, Peter
    Voskova, Daniela
    Rossmann, Dieter H.
    Schlick, Konstantin
    Thaler, Josef
    Halter, Britta
    Machherndl-Spandl, Sigrid
    Theiler, Georg
    Valent, Peter
    Eckmuellner, Otto
    Greil, Richard
    BLOOD, 2014, 124 (21)
  • [42] A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes
    Mikkael A. Sekeres
    Michael Schuster
    Magalie Joris
    Jürgen Krauter
    Johan Maertens
    Dimitri Breems
    Emmanuel Gyan
    Tibor Kovacsovics
    Amit Verma
    Paresh Vyas
    Eunice S. Wang
    Keith Ching
    Thomas O’Brien
    Corrado Gallo Stampino
    Weidong Wendy Ma
    Arthur Kudla
    Geoffrey Chan
    Amer M. Zeidan
    Annals of Hematology, 2022, 101 : 1689 - 1701
  • [43] A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients
    Cooper, Brenda W.
    Kindwall-Keller, Tamila L.
    Craig, Michael D.
    Creger, Richard J.
    Hamadani, Mehdi
    Tse, William W.
    Lazarus, Hillard M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (07): : 428 - 432
  • [44] Acute myeloid leukemia (AML): A study of 516 patients
    Kumar, L
    Menon, H
    Sharma, A
    Wadhwa, J
    Kumar, R
    Kochupillai, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 610S - 610S
  • [45] Azacitidine in adult patients with acute myeloid leukemia
    Schuh, Andre C.
    Doehner, Hartmut
    Pleyer, Lisa
    Seymour, John F.
    Fenaux, Pierre
    Dombret, Herve
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 116 : 159 - 177
  • [47] Azacitidine for the treatment of patients with acute myeloid leukemia
    Maurillo, Luca
    Venditti, Adriano
    Spagnoli, Alessandra
    Gaidano, Gianluca
    Ferrero, Dario
    Oliva, Esther
    Lunghi, Monia
    D'Arco, Alfonso M.
    Levis, Alessandro
    Pastore, Domenico
    Di Renzo, Nicola
    Santagostino, Alberto
    Pavone, Vincenzo
    Buccisano, Francesco
    Musto, Pellegrino
    CANCER, 2012, 118 (04) : 1014 - 1022
  • [49] Azacitidine in Older Patients with Acute Myeloid Leukemia (AML) and Adverse Karyotype. Subanalisis from the Alma Study
    Falantes, Jose
    Deben, Guillermo
    Martinez Robles, Violeta
    Bargay, Joan
    Salamero, Olga
    Pedro, Carmen
    Redondo, Santiago
    Garrido, Ana
    Miguel Bergua, Juan
    Tormo, Mar
    Xicoy, Blanca
    Font, Patricia
    Jose Gonzalez-Lopez, Tomas
    Ramos, Fernando
    BLOOD, 2014, 124 (21)
  • [50] Correlation between mutation clearance and clinical response in elderly patients with acute myeloid leukemia (AML) treated with azacitidine and pracinostat.
    Takahashi, Koichi
    Abaza, Yasmin
    Atallah, Ehab L.
    Medeiros, Bruno C.
    Khal, Sam
    Arellano, Martha Lucia
    Patnaik, Mrinal
    Ghalie, Richard
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35